Supreme Court to Decide on Abortion Medication Access Amid State Restrictions
The U.S. Supreme Court is set to decide whether to take up a case that could significantly impact the availability of medication-only abortion procedures. This follows a series of state-level restrictions that have emerged since the 2022 Dobbs decision, which returned the power to regulate abortion to individual states. In response, several states, including California, have enacted laws to protect access to abortion-inducing medications like mifepristone, often prescribed via telehealth. However, states with strict abortion bans, such as Louisiana, are challenging these measures. Louisiana is suing the Food and Drug Administration (FDA) over its approval of mifepristone for telehealth prescriptions, arguing that it poses safety risks. The Supreme Court recently lifted a stay that had halted the tele-prescription of mifepristone, allowing its use until at least May 11, 2026. 
